The solution, she thinks, is to be prepared to leave patients on the drugs for life if they need it, perhaps cycling a patient on to a lower dose or less efficacious medication over time
For systemic research, certain contraindications exist, such as pregnancy, breastfeeding, active cancer, or conditions like Wilsons disease (a genetic disorder causing copper accumulation)
Int J Pancreatology 7: 325-330, 1990
Am J Physiol Endocrinol Metab 310 : E744E753, 2016
Since patients in the study population with obesity were for the first time prescribed semaglutide after 6/2021, there was no overlap in the exposure cohorts for these two study populations